Categories AlphaGraphs, Earnings, Health Care
Key highlights from Pfizer (PFE) Q3 2021 earnings results
Pfizer Inc. (NYSE: PFE) reported third quarter 2021 earnings results today.
Revenues more than doubled year-over-year to $24 billion.
Reported net income was $8.1 billion, or $1.42 per share, compared to $1.4 billion, or $0.26 per share, in the year-ago period. Adjusted net income more than doubled YoY to $7.6 billion, or $1.34 per share.
Both revenue and earnings beat expectations.
The company raised its guidance for the full year of 2021 and now expects revenue to range between $81-82 billion and adjusted EPS to range between $4.13-4.18. This compares to the previous outlook for revenue of $78-80 billion and adjusted EPS of $3.95-4.05.
Prior performance
Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on
